Specialty pharmaceutical company ULURU has introduced Altrazeal in a 0.75gm blister pack targeting US chronic wound market. New packaging system provides information regarding appropriate quantity for the treatment of chronic wounds and ...
Tags: ULURU, blister pack, pharmaceutical company
Pharmaceutical company Uluru has announced the availability of Altrazeal, an advanced scientifically engineered material, in a new 0.75g blister pack in the US market. The configuration of the packaging overcomes various concerns ...
Tags: pharmaceutical company, Uluru, Altrazeal, blister pack
Pharmaceutical company in the US, ULURU has completed the initial production of the Altrazeal 0.75g transparent blister pack. The Altrazeal 0.75g blister pack, which completed test marketing in the US and Europe, incorporates an ...
Tags: ULURU, CEO, smaller chronic wounds
Uluru said that the first shipment of Altrazeal has been received by its marketing partner in Australia. Altrazeal, a wound treatment technology, has shown clinical and economic advantages in a number of chronic and acute wounds, which ...
Tags: Altrazeal, wound treatment technology, marketing partner